This Section has restricted access and is intended solely and exclusively for
If you are not a healthcare expert, you are not granted and are disallowed access to the information contained in this Section, and you may not review it.
Are you a healthcare expert?
Subscribe to the news?
You have successfully signed up!
We improve the quality and extend interaction with healthcare professionals, due to this we launch a webinar portal.
On March 4, the very first and unique online webinar was held within the "Glatiramer acetate 40 mg" symposium: Today principles and optimization of therapy for patients with remittent multiple sclerosis.
This transaction strengthens Teva's strategy, facilitates an accelerated transition to a new business model and opens up new opportunities for the company in the production of generics and specialty. The company provides medicinal products to 250 million people around the world every day.